3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Prostatic Neoplasms
5
Urinary Bladder Neoplasms
3
Breast Neoplasms
3
Neoplasms
2
Colorectal Neoplasms
2
Triple Negative Breast Neoplasms
1
Stress Disorders, Post-Traumatic
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Myelodysplastic Syndromes
1
Muscle-invasive Bladder Cancer
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Kidney Failure, Chronic
1
Idiopathic Pulmonary Fibrosis
1
Hypertension
1
Esophageal Neoplasms
1
Disease Progression
1
Diabetes Mellitus
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Nutrition Assessment
2
pazopanib
1
enzalutamide
1
bicalutamide
1
Vitamin D
1
Resistance Training
1
Receptors, Androgen
1
Polymorphism, Genetic
1
Palliative Care
1
Lysine Acetyltransferase 5
1
Leuprolide
1
Goserelin
1
Flutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypertension
×
Palliative Care
×
Genitourinary
×
Clear all
NCT04836221
2023-06-18
CARES
Medstar Health Research Institute
Phase NA
Completed
63 enrolled